Osteoporosis Research Updates

For Medical Professionals

US researchers evaluated the impact of Better Bones and Balance (BBB)—a community-based exercise program to reduce fall and fracture risk—in a community setting.
A study out of the UK looked at the specific role dietary fats and exercise play in postmenopausal women who have osteoporosis.
US researchers investigated the long-term safety and effectiveness of once-monthly ibandronate, which was studied for up to 5 years in a long-term extension.
It’s well known that exercise can help prevent osteoporosis, but how effective is high-impact exercise on osteoporosis?
Reclast is an osteoporosis medication, and in September 2011, the FDA issued a new warning label for it. It may cause renal impairment, so physicians should be cautious before prescribing. Article reviews new FDA label for Reclast.
Research comparing the safety and effectiveness of oral minodronate at monthly doses of 30 mg or 50 mg to a daily dose of 1 mg in patients with osteoporosis.
Are high doses of vitamin D3 better than the standard dose for boosting bone mineral density and decreasing bone turnover in post-menopausal women who have low bone mass?